CHRONIC PSYCHOSIS IN EPILEPSY: A CLINICAL INVESTIGATION OF 29 PATIENTSPARNAS J; KORSGAARD S; KRAUTWALD O et al.1982; ACTA PSYCHIATRICA SCANDINAVICA; ISSN 0001-690X; DNK; DA. 1982; VOL. 66; NO 4; PP. 282-293; BIBL. 15 REF.Article

RELEVANCE OF TRYPTOPHAN AND TYROSINE AVAILABILITY IN ENDOGENOUS AND "NON-ENDOGENOUS" DEPRESSIVES TREATED WITH IMIPRAMINE OR CLOMIPRAMINEMOLLER SE; REISBY N; ORTMANN J et al.1981; J. AFFECTIVE DISORD.; ISSN 0165-0327; NLD; DA. 1981; VOL. 3; NO 3; PP. 231-244; BIBL. 3 P.Article

IMIPRAMINE: CLINICAL EFFECTS AND PHARMACOKINETIC VARIABILITY.REISBY N; GRAM LF; BECH P et al.1977; PSYCHOPHARMACOLOGY; GERM.; DA. 1977; VOL. 54; NO 3; PP. 263-272; BIBL. 28 REF.Article

STEADY-STATE KINETICS OF IMIPRAMINE IN PATIENTS.GRAM LF; SONDERGAARD I; CHRISTIANSEN J et al.1977; PSYCHOPHARMACOLOGY; GERM.; DA. 1977; VOL. 54; NO 3; PP. 255-261; BIBL. 24 REF.Article

Biochemical and diagnostic classification and serum drug levels: relation to antidepressive effect of imipramineMOLLER, S. E; REISBY, N; ELLEY, J et al.Neuropsychobiology. 1985, Vol 13, Num 4, pp 160-166, issn 0302-282XArticle